Table 4 ADR probability scale for suspected ADRs associated with antineoplastic monoclonal antibodies [28]
| Â | Total Number | % | Doubtfula ADRs | Possibleb ADRs | Probablec ADRs | Definited ADRs |
|---|---|---|---|---|---|---|
Heart failure | 50 | 4.7% | 0 | 25 | 25 | 0 |
Hypertension | 60 | 5.6% | 1 | 46 | 13 | 0 |
Ischemic heart disease | 2 | 0.19% | 0 | 2 | 0 | 0 |
Arrhythmia | 4 | 0.37% | 0 | 3 | 1 | 0 |
Thromboembolic event | 32 | 3.0% | 1 | 22 | 8 | 1 |
Hemorrhage | 26 | 2.4% | 1 | 20 | 5 | 0 |